Phase 3 Data for KEYTRUDA® as Neoadjuvant Therapy in Combination with Chemotherapy in Patients with Triple-Negative Breast Cancer to be Featured in ES

source https://finance.yahoo.com/news/pivotal-data-merck-broad-oncology-104500818.html?.tsrc=rss